Evidence map›Paper›PMID 41245224›Full record

ArticleCanadian journal of gastroenterology & hepatology2025

Efficacy and Safety of Microwave Ablation in Patients With Hepatocellular Carcinoma With Decompensated Liver Cirrhosis: A Retrospective Study.

Jihua Xue, Yuting Gu, Ji Li, Junfei Zhang, Tingting Bian, Zhongsong Zhou, Yufeng Gao

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Canadian journal of gastroenterology & hepatology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Jihua XueDepartment of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China, ahmu.edu.cn.ORCID 0009-0000-4820-9020
Yuting GuDepartment of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China, ahmu.edu.cn.ORCID 0009-0003-2431-1030
Ji LiDepartment of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China, ahmu.edu.cn.ORCID 0000-0002-0868-2363
Junfei ZhangDepartment of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China, ahmu.edu.cn.ORCID 0009-0007-4660-3391
Tingting BianDepartment of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China, ahmu.edu.cn.ORCID 0000-0001-9836-7246
Zhongsong ZhouDepartment of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China, ahmu.edu.cn.ORCID 0000-0002-0927-2905
Yufeng GaoDepartment of Infectious Diseases, The First Affiliated Hospital of Anhui Medical University, Hefei, 230022, Anhui, China, ahmu.edu.cn.ORCID 0000-0003-1822-8161

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Except for liver transplantation, no definitive treatment exists for hepatocellular carcinoma (HCC) in individuals suffering from decompensated liver cirrhosis. This research evaluated the feasibility and outcomes of microwave ablation (MWA) treatment in this patient population. Methods: This research involved individuals diagnosed with HCC and decompensated cirrhosis who underwent MWA between 2019 and 2022. The analysis examined complications associated with the procedure, the effectiveness of treatment, patient survival rates, and the variations in blood test results and liver function reserves before and after MWA. Results: The 62 enrolled patients were predominantly male ( Conclusion: MWA is a safe procedure for individuals with HCC and decompensated liver cirrhosis. CR is associated with a better prognosis.

Indexed as

Carcinoma, HepatocellularHepatitis BLiver CirrhosisLiver NeoplasmsMicrowavesRadiofrequency AblationAdultAgedDisease ProgressionFeasibility StudiesFemaleFollow-Up StudiesHumansLiver Function TestsMaleMiddle Ageddecompensatedhepatocellular carcinomaliver cirrhosismicrowave ablation

Identifiers

PMID41245224
PMCPMC12611878

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.